Atlas Trials

Prospective Validation of 3D Dose Metrics as Selection Criteria for Adaptive Radiotherapy in Breast Cancer Patients

Clinical trial NCT03385031 · COMPLETED

Trial details

NCT number
NCT03385031
Sponsor
Maastricht Radiation Oncology
Status
COMPLETED
Study type
OBSERVATIONAL
Breast Cancer
Start date
2018-01-01
Primary completion
2018-08-20
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.